[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EE200000330A - Farmatseutilised kompositsioonid - Google Patents

Farmatseutilised kompositsioonid

Info

Publication number
EE200000330A
EE200000330A EEP200000330A EEP200000330A EE200000330A EE 200000330 A EE200000330 A EE 200000330A EE P200000330 A EEP200000330 A EE P200000330A EE P200000330 A EEP200000330 A EE P200000330A EE 200000330 A EE200000330 A EE 200000330A
Authority
EE
Estonia
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
EEP200000330A
Other languages
English (en)
Inventor
Jane Corvari Susan
Richard Creekmore Joseph
Original Assignee
Astrazeneca Uk Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Limited filed Critical Astrazeneca Uk Limited
Publication of EE200000330A publication Critical patent/EE200000330A/et
Publication of EE04260B1 publication Critical patent/EE04260B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EEP200000330A 1997-12-18 1998-12-15 Farmatseutiline kompositsioon, selle valmistamisemeetod ja kasutamine EE04260B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726735.5A GB9726735D0 (en) 1997-12-18 1997-12-18 Pharmaceutical compositions
PCT/GB1998/003765 WO1999032082A2 (en) 1997-12-18 1998-12-15 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
EE200000330A true EE200000330A (et) 2001-08-15
EE04260B1 EE04260B1 (et) 2004-04-15

Family

ID=10823809

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000330A EE04260B1 (et) 1997-12-18 1998-12-15 Farmatseutiline kompositsioon, selle valmistamisemeetod ja kasutamine

Country Status (30)

Country Link
US (1) US6399104B1 (et)
EP (1) EP1041966B1 (et)
JP (1) JP2001526206A (et)
KR (1) KR20010033206A (et)
CN (1) CN1282244A (et)
AR (1) AR017884A1 (et)
AT (1) ATE243999T1 (et)
AU (1) AU744326C (et)
BR (1) BR9813666A (et)
CA (1) CA2313163A1 (et)
DE (1) DE69816124T2 (et)
DK (1) DK1041966T3 (et)
EE (1) EE04260B1 (et)
ES (1) ES2202915T3 (et)
GB (1) GB9726735D0 (et)
HU (1) HUP0004669A3 (et)
ID (1) ID25857A (et)
IL (1) IL136501A0 (et)
IN (1) IN191311B (et)
MY (1) MY133096A (et)
NO (1) NO20003141D0 (et)
NZ (1) NZ504566A (et)
PL (1) PL341736A1 (et)
PT (1) PT1041966E (et)
RU (1) RU2205006C2 (et)
SK (1) SK9402000A3 (et)
TR (1) TR200001713T2 (et)
UA (1) UA62991C2 (et)
WO (1) WO1999032082A2 (et)
ZA (1) ZA9811532B (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO319624B1 (no) 2003-09-15 2005-09-05 Trouw Internat Bv Fiskefôr for laksefisk i ferskvann og anvendelse av slikt fôr.
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
DE102006006532B4 (de) * 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
DE602007013567D1 (de) * 2006-08-16 2011-05-12 Novartis Ag Verfahren zur herstellung fester dispersionen von midostaurin
KR20090122489A (ko) * 2007-03-26 2009-11-30 데이코쿠 세이야쿠 가부시키가이샤 결장-특이적 전달을 위한 경구적 약제학적 제제
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
US11872210B2 (en) 2017-01-30 2024-01-16 Western New England University Thiol isomerases inhibitors and use thereof
CN107714694A (zh) * 2017-11-01 2018-02-23 天津国际生物医药联合研究院 扎鲁司特在抗结核分枝杆菌感染中的应用
JP2024521736A (ja) 2021-05-19 2024-06-04 クエルシス ファーマ エージー 筋萎縮性側索硬化症の治療に使用するためのケルセチン含有組成物
WO2023214391A1 (en) 2022-05-06 2023-11-09 Quercis Pharma AG Method for treating cancers and neurological diseases using quercetin-containing compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)

Also Published As

Publication number Publication date
DK1041966T3 (da) 2003-10-06
DE69816124D1 (de) 2003-08-07
SK9402000A3 (en) 2001-01-18
HUP0004669A1 (hu) 2001-08-28
ID25857A (id) 2000-11-09
PT1041966E (pt) 2003-11-28
CN1282244A (zh) 2001-01-31
KR20010033206A (ko) 2001-04-25
JP2001526206A (ja) 2001-12-18
EP1041966A2 (en) 2000-10-11
AU744326C (en) 2002-11-07
HUP0004669A3 (en) 2005-03-29
EE04260B1 (et) 2004-04-15
BR9813666A (pt) 2000-10-10
NO20003141L (no) 2000-06-16
NZ504566A (en) 2002-10-25
IL136501A0 (en) 2001-06-14
UA62991C2 (en) 2004-01-15
AU744326B2 (en) 2002-02-21
GB9726735D0 (en) 1998-02-18
AU1571199A (en) 1999-07-12
EP1041966B1 (en) 2003-07-02
US6399104B1 (en) 2002-06-04
RU2205006C2 (ru) 2003-05-27
WO1999032082A3 (en) 1999-09-16
PL341736A1 (en) 2001-05-07
ATE243999T1 (de) 2003-07-15
AR017884A1 (es) 2001-10-24
WO1999032082A2 (en) 1999-07-01
NO20003141D0 (no) 2000-06-16
IN191311B (et) 2003-11-22
CA2313163A1 (en) 1999-07-01
ES2202915T3 (es) 2004-04-01
MY133096A (en) 2007-10-31
ZA9811532B (en) 1999-06-18
TR200001713T2 (tr) 2000-10-23
DE69816124T2 (de) 2004-05-06

Similar Documents

Publication Publication Date Title
IS5046A (is) Lyfjasamsetningar
ID27415A (id) Komposisi farmaseutik
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
NO995925D0 (no) Farmasöytiske sammensetninger omfattende cyklodekstriner
ID22931A (id) Komposisi-komposisi herbisidal
IS4706A (is) Lyfjasamsetningar
ID24654A (id) Formulasi farmasi omeprazola
ID18352A (id) Komposisi-komposisi farmasi
EE9900055A (et) Farmatseutilised aerosoolkompositsioonid
DK1298194T3 (da) Staniolholdige sammensætninger
ID29262A (id) Komposisi farmasi
ID27201A (id) Komposisi farmasi
ID25650A (id) Komposisi-komposisi sampo
PT969815E (pt) Composicoes farmaceuticas
EE200000330A (et) Farmatseutilised kompositsioonid
DE69826706D1 (de) Wäscheweichmittelzusammensetzungen
PT941100E (pt) Composicoes farmaceuticas
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
IS2200B (is) Lyfjasamsetningar
ITMI962628A0 (it) Composizione farmaceutica
NO994436D0 (no) Farmasöytiske sammensetninger
FI962738A0 (fi) Farmaseuttiset koostumukset
BR1100755A (pt) composição farmacêutica
SE9800052D0 (sv) Pharmaceutical compositions
FI981567A0 (fi) Farmaseuttiset koostumukset

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20041231

MM4A Lapsed by not paying the annual fees

Effective date: 20041215